Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies. A jury in October found the companies not ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

In a report released today, Guillaume Delmas from UBS maintained a Buy rating on Reckitt (RKT – Research Report), with a price target of £77.00. See what stocks are receiving Strong Buy ratings ...

Bernstein analyst Callum Elliott maintained a Hold rating on Reckitt (RKT – Research Report) today and set a price target of £55.00. See what stocks are receiving Strong Buy ratings from top ...

JOHOR BAHRU: The five-year plan unveiled for Johor to develop three more reservoirs alongside three water treatment plants so that it no longer needs to rely on Singapore for treated water by 2030 ...

Investing.com - Reckitt Benckiser (LON:RKT) stock retreated Friday amid uncertainty over its liabilities surrounding its Mead Johnson infant-formula business. At 06:55 ET (10:55 GMT), Reckitt stoc ...

Shares of Abbott Laboratories and Reckitt Benckiser Group slid this morning following a Missouri state court granting the plaintiff a retrial in a baby formula case the companies previously won.

Reckitt Benckiser’s profits fell short of analysts’ expectations last year, despite burgeoning hopes of a turnaround at the consumer goods giant. The owner of brands like Strepsils, Dettol and Lemsip, ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...